Sequential parenteral and oral ciprofloxacin regimen versus parenteral therapy for bacteremia

A pharmacoeconomic analysis

Maria Amodio-Groton, Assumpta Madu, Christian N. Madu, Laurie L. Briceland, Marissa Seligman, Pamela McMaster, Michael H. Miller

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Objective: To compare, in patients with gram-negative bacteremia, a course of parenteral antibiotic therapy alone with initial parenteral therapy followed by oral ciprofloxacin in terms of the length of hospitalization, clinical effectiveness, toxicity, and cost. Design: A prospective, controlled, randomized, open trial in select hospitalized patients. Setting: A large metropolitan teaching hospital. Patients: Fifty hospitalized patients with proven gram-negative bacteremia were randomized to received either oral ciprofloxacin (group 1) following a 72-hour initial intravenous antibiotic regimen or to continue parenteral therapy alone (group 2). To compare the length of hospitalization, an additional group of 50 hospitalized patients with bacteremia (not enrolled in the study, group 3) were analyzed. Intervention: Parental antibiotics for 72 hours followed by continuation of a parenteral regimen or oral ciprofloxacin 750 mg bid. Main Outcome Measures: Clinical response, toxicity, and length of hospitalization. Results: Clinical resolution was comparable in the 24 group 1 patients receiving intravenous antibiotics followed by oral ciprofloxacin (83%), the 26 group 2 patients receiving parenteral therapy alone (77%), and the 50 comparison patients (76%). There was little toxicity noted in any group, and the initial parenteral antibiotic regimens were similar. The mean numbers of hospital days on antibiotics were 9.1, 11.2, and 10.6 days in groups 1, 2, and 3, respectively (p<0.05 for group 1 vs. group 2 or 3), and the lengths of hospitalization were 9.8, 15.7, and 12.1 days, respectively (p<0.05 for group 1 vs. group 2 or 3). Shortening the length of hospitalization and days of antibiotic therapy was associated with a cost saving of up to $78 000 for group 1 patients. Conclusions: Parenteral therapy for 72 hours followed by oral ciprofloxacin significantly shortened both the number of hospital days taking antibiotics and the length of stay compare with parental therapy of gram-negative bacteremia, and initial parenteral therapy followed by oral ciprofloxacin was cost-effective.

Original languageEnglish (US)
Pages (from-to)596-602
Number of pages7
JournalAnnals of Pharmacotherapy
Volume30
Issue number6
StatePublished - 1996

Fingerprint

Pharmaceutical Economics
Ciprofloxacin
Bacteremia
Anti-Bacterial Agents
Hospitalization
Therapeutics
Costs and Cost Analysis
Hospitalization Insurance
Urban Hospitals
Group Psychotherapy
Teaching Hospitals
Length of Stay
Randomized Controlled Trials
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Amodio-Groton, M., Madu, A., Madu, C. N., Briceland, L. L., Seligman, M., McMaster, P., & Miller, M. H. (1996). Sequential parenteral and oral ciprofloxacin regimen versus parenteral therapy for bacteremia: A pharmacoeconomic analysis. Annals of Pharmacotherapy, 30(6), 596-602.

Sequential parenteral and oral ciprofloxacin regimen versus parenteral therapy for bacteremia : A pharmacoeconomic analysis. / Amodio-Groton, Maria; Madu, Assumpta; Madu, Christian N.; Briceland, Laurie L.; Seligman, Marissa; McMaster, Pamela; Miller, Michael H.

In: Annals of Pharmacotherapy, Vol. 30, No. 6, 1996, p. 596-602.

Research output: Contribution to journalArticle

Amodio-Groton, M, Madu, A, Madu, CN, Briceland, LL, Seligman, M, McMaster, P & Miller, MH 1996, 'Sequential parenteral and oral ciprofloxacin regimen versus parenteral therapy for bacteremia: A pharmacoeconomic analysis', Annals of Pharmacotherapy, vol. 30, no. 6, pp. 596-602.
Amodio-Groton M, Madu A, Madu CN, Briceland LL, Seligman M, McMaster P et al. Sequential parenteral and oral ciprofloxacin regimen versus parenteral therapy for bacteremia: A pharmacoeconomic analysis. Annals of Pharmacotherapy. 1996;30(6):596-602.
Amodio-Groton, Maria ; Madu, Assumpta ; Madu, Christian N. ; Briceland, Laurie L. ; Seligman, Marissa ; McMaster, Pamela ; Miller, Michael H. / Sequential parenteral and oral ciprofloxacin regimen versus parenteral therapy for bacteremia : A pharmacoeconomic analysis. In: Annals of Pharmacotherapy. 1996 ; Vol. 30, No. 6. pp. 596-602.
@article{b64616139de74561ba72d1317e696b86,
title = "Sequential parenteral and oral ciprofloxacin regimen versus parenteral therapy for bacteremia: A pharmacoeconomic analysis",
abstract = "Objective: To compare, in patients with gram-negative bacteremia, a course of parenteral antibiotic therapy alone with initial parenteral therapy followed by oral ciprofloxacin in terms of the length of hospitalization, clinical effectiveness, toxicity, and cost. Design: A prospective, controlled, randomized, open trial in select hospitalized patients. Setting: A large metropolitan teaching hospital. Patients: Fifty hospitalized patients with proven gram-negative bacteremia were randomized to received either oral ciprofloxacin (group 1) following a 72-hour initial intravenous antibiotic regimen or to continue parenteral therapy alone (group 2). To compare the length of hospitalization, an additional group of 50 hospitalized patients with bacteremia (not enrolled in the study, group 3) were analyzed. Intervention: Parental antibiotics for 72 hours followed by continuation of a parenteral regimen or oral ciprofloxacin 750 mg bid. Main Outcome Measures: Clinical response, toxicity, and length of hospitalization. Results: Clinical resolution was comparable in the 24 group 1 patients receiving intravenous antibiotics followed by oral ciprofloxacin (83{\%}), the 26 group 2 patients receiving parenteral therapy alone (77{\%}), and the 50 comparison patients (76{\%}). There was little toxicity noted in any group, and the initial parenteral antibiotic regimens were similar. The mean numbers of hospital days on antibiotics were 9.1, 11.2, and 10.6 days in groups 1, 2, and 3, respectively (p<0.05 for group 1 vs. group 2 or 3), and the lengths of hospitalization were 9.8, 15.7, and 12.1 days, respectively (p<0.05 for group 1 vs. group 2 or 3). Shortening the length of hospitalization and days of antibiotic therapy was associated with a cost saving of up to $78 000 for group 1 patients. Conclusions: Parenteral therapy for 72 hours followed by oral ciprofloxacin significantly shortened both the number of hospital days taking antibiotics and the length of stay compare with parental therapy of gram-negative bacteremia, and initial parenteral therapy followed by oral ciprofloxacin was cost-effective.",
author = "Maria Amodio-Groton and Assumpta Madu and Madu, {Christian N.} and Briceland, {Laurie L.} and Marissa Seligman and Pamela McMaster and Miller, {Michael H.}",
year = "1996",
language = "English (US)",
volume = "30",
pages = "596--602",
journal = "Annals of Pharmacotherapy",
issn = "1060-0280",
publisher = "Harvey Whitney Books Company",
number = "6",

}

TY - JOUR

T1 - Sequential parenteral and oral ciprofloxacin regimen versus parenteral therapy for bacteremia

T2 - A pharmacoeconomic analysis

AU - Amodio-Groton, Maria

AU - Madu, Assumpta

AU - Madu, Christian N.

AU - Briceland, Laurie L.

AU - Seligman, Marissa

AU - McMaster, Pamela

AU - Miller, Michael H.

PY - 1996

Y1 - 1996

N2 - Objective: To compare, in patients with gram-negative bacteremia, a course of parenteral antibiotic therapy alone with initial parenteral therapy followed by oral ciprofloxacin in terms of the length of hospitalization, clinical effectiveness, toxicity, and cost. Design: A prospective, controlled, randomized, open trial in select hospitalized patients. Setting: A large metropolitan teaching hospital. Patients: Fifty hospitalized patients with proven gram-negative bacteremia were randomized to received either oral ciprofloxacin (group 1) following a 72-hour initial intravenous antibiotic regimen or to continue parenteral therapy alone (group 2). To compare the length of hospitalization, an additional group of 50 hospitalized patients with bacteremia (not enrolled in the study, group 3) were analyzed. Intervention: Parental antibiotics for 72 hours followed by continuation of a parenteral regimen or oral ciprofloxacin 750 mg bid. Main Outcome Measures: Clinical response, toxicity, and length of hospitalization. Results: Clinical resolution was comparable in the 24 group 1 patients receiving intravenous antibiotics followed by oral ciprofloxacin (83%), the 26 group 2 patients receiving parenteral therapy alone (77%), and the 50 comparison patients (76%). There was little toxicity noted in any group, and the initial parenteral antibiotic regimens were similar. The mean numbers of hospital days on antibiotics were 9.1, 11.2, and 10.6 days in groups 1, 2, and 3, respectively (p<0.05 for group 1 vs. group 2 or 3), and the lengths of hospitalization were 9.8, 15.7, and 12.1 days, respectively (p<0.05 for group 1 vs. group 2 or 3). Shortening the length of hospitalization and days of antibiotic therapy was associated with a cost saving of up to $78 000 for group 1 patients. Conclusions: Parenteral therapy for 72 hours followed by oral ciprofloxacin significantly shortened both the number of hospital days taking antibiotics and the length of stay compare with parental therapy of gram-negative bacteremia, and initial parenteral therapy followed by oral ciprofloxacin was cost-effective.

AB - Objective: To compare, in patients with gram-negative bacteremia, a course of parenteral antibiotic therapy alone with initial parenteral therapy followed by oral ciprofloxacin in terms of the length of hospitalization, clinical effectiveness, toxicity, and cost. Design: A prospective, controlled, randomized, open trial in select hospitalized patients. Setting: A large metropolitan teaching hospital. Patients: Fifty hospitalized patients with proven gram-negative bacteremia were randomized to received either oral ciprofloxacin (group 1) following a 72-hour initial intravenous antibiotic regimen or to continue parenteral therapy alone (group 2). To compare the length of hospitalization, an additional group of 50 hospitalized patients with bacteremia (not enrolled in the study, group 3) were analyzed. Intervention: Parental antibiotics for 72 hours followed by continuation of a parenteral regimen or oral ciprofloxacin 750 mg bid. Main Outcome Measures: Clinical response, toxicity, and length of hospitalization. Results: Clinical resolution was comparable in the 24 group 1 patients receiving intravenous antibiotics followed by oral ciprofloxacin (83%), the 26 group 2 patients receiving parenteral therapy alone (77%), and the 50 comparison patients (76%). There was little toxicity noted in any group, and the initial parenteral antibiotic regimens were similar. The mean numbers of hospital days on antibiotics were 9.1, 11.2, and 10.6 days in groups 1, 2, and 3, respectively (p<0.05 for group 1 vs. group 2 or 3), and the lengths of hospitalization were 9.8, 15.7, and 12.1 days, respectively (p<0.05 for group 1 vs. group 2 or 3). Shortening the length of hospitalization and days of antibiotic therapy was associated with a cost saving of up to $78 000 for group 1 patients. Conclusions: Parenteral therapy for 72 hours followed by oral ciprofloxacin significantly shortened both the number of hospital days taking antibiotics and the length of stay compare with parental therapy of gram-negative bacteremia, and initial parenteral therapy followed by oral ciprofloxacin was cost-effective.

UR - http://www.scopus.com/inward/record.url?scp=0029941386&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029941386&partnerID=8YFLogxK

M3 - Article

VL - 30

SP - 596

EP - 602

JO - Annals of Pharmacotherapy

JF - Annals of Pharmacotherapy

SN - 1060-0280

IS - 6

ER -